Evaluation of the natural killer cytotoxicity and the levels of cytokines in rats with type i diabetes mellitus

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 8, 2005, Pages 883-887

  Fidan, Isil ^a   Yüksel, Sevgi ^a   Kalkanci, Ayse ^a   Imir, Turgut ^a   Kustimur, Semra ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Cytokines; Natural killer cells; Type 1 diabetes mellitus

Indexed keywords

EID: 32244443896     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762005000800010     Document Type: Article

References (22)

1. Abbas AK, Lichtman AH 2003. Innate immunity. In J Malley, H Krehling (eds), Cellular and Molecular Immunology, Saunders, Philadelphia, p. 275-297.
2. Baxter AG, Smyth MJ 2002. The role of NK Cells in disease. Autoimmunity 35: 1-14.
3. Boitard C 2002 The origin of type 1 diabetes: An disease? Diabetes Metab 28: 263-265.
4. Cetkovic-Cvrlje M, Uckun F 2005. Effect of targeted disruption of signal transducer and activator of transcription (Stat)4 and Stat6 genes on the diabets development induced by multipl low doses of streptozotocin. Clin Immunol 114: 299-306.
5. Coutant R, Landais P, Rosilio M 1998. Low dose linomide in type 1 juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial, Diabetologia 41: 1040-1046.
6. Ellerman K, Wrobleski M, Rabinovitch A, Like A 1993. Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited). Diabetologia 36: 596-601.
7. Gülay Z, Imir T 1996. Anti-candidal activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro. Immunobiology 195: 220-230.
8. Hayashi T, Morimoto M, Iwata H, Onodera T 1998. Interferon-γ plays a role in pancreatic islet-cell destruction of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice. Int J Exp Pathol 79: 313-320.
9. Hussain MJ, Alviggi L, Millward BA, Leslie RDG, Pyke DA, Vergani D 1987. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined. Diabetologia 30: 907-911.
10. Johansson SE, Hall H, Björklund J, Hoglund P 2004. Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-8 in vitro. Intern Immunol 16: 1-11.
11. Lo HC, Lin SC, Wang YM 2004. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clin Biochem 37: 666-672.
12. Lorini R, Moretta A, Valtorta A, d'Annunzio G 1994. Cytotoxic activity in children with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 23: 37-42.
13. Mackay P, Jacobson J, Rabinovitch A 1986. Spontaneous Diabetes mellitus in the Bio-Breeding/Worcester rat. J Clin Invest 77: 916-924.
14. Monetini L, Cavallo MG, Sarugeri E 2004. Cytokines profile and insulin antibody IgG subclasses in patients with recent onset Type 1 diabetes treated with oral insulin. Diabetalogia 47: 1795-1802.
15. Negishi K, Waldeck N, Chandy G 1986. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes. Diabetologia 29: 352-357.
16. Poirot L, Benoist C, Mathis D 2004. Natural killer cells disinguish innocuous and destructive forms of pancreatic islet autoimmunity. PNAS 101: 8102-8107.
17. Poulton LD, Smyth MJ, Hawke CG 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Intern Immunol 13: 887-896.
18. Rabinovitch A 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14: 129-151.
19. Rapoport MJ, Mor A, Vardi P, Ramot Y, Winkr R, Hindi A, Bistritzer T 1998. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmune 11: 635-642.
20. Schloot NC, Hanifi-Moghaddam P, Goebel C 2002. Serum IFN-γ and IL-10 levels are associated with disease progression in non-obese diabetic mice. Diabetes Metab Res Rev 18: 64-70.
21. Suk K, Kim S, Kim YH 2001. IFN-γ/TNF-α synergism as the final effector in diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic b cell death. J Immunol 166: 4481-4489.
22. Zhang XF, Tan BKH 2000. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med 41: 9-13.